Drug Approved to Prevent Respiratory Distress Syndrome
WEDNESDAY, March 7 (Healthday News) -- Sufaxin (lucinacant) has been approved by the U.S. Food And Drug Administration to prevent respiratory distress syndrome, a serious lung condition that affects infants born prematurely. read more..
source:http://yhoo.it/yVfGRY
No comments:
Post a Comment